Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,551.61
+47.46 (3.16%)
At close: Aug 25, 2026
EGX:AXPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 7,758 | 2,228 | 1,054 | 691 | 529 | 675 | |
Market Cap Growth | 137.74% | 111.49% | 52.48% | 30.54% | -21.61% | 6.68% |
Enterprise Value | 7,348 | 2,058 | 916 | 546 | 489 | 612 |
Last Close Price | 1551.61 | 414.37 | 177.60 | 107.31 | 74.62 | 88.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 15.55 | 5.70 | 4.86 | 5.47 | 4.51 | 5.77 |
Forward PE | - | 4.57 | 4.57 | 4.57 | 4.57 | 4.30 |
PS Ratio | 2.49 | 0.81 | 0.60 | 0.47 | 0.48 | 0.61 |
PB Ratio | 7.15 | 2.24 | 1.33 | 1.05 | 0.86 | 1.15 |
P/TBV Ratio | 7.15 | 2.24 | 1.33 | 1.05 | 0.86 | 1.15 |
P/FCF Ratio | 14.29 | 7.28 | 8.27 | 97.40 | 3.29 | - |
P/OCF Ratio | 12.74 | 6.63 | 5.56 | 7.57 | 2.75 | 6.79 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 2.36 | 0.75 | 0.52 | 0.37 | 0.45 | 0.55 |
EV/EBITDA Ratio | 10.65 | 3.76 | 3.00 | 2.99 | 3.10 | 3.44 |
EV/EBIT Ratio | 11.40 | 4.08 | 3.43 | 3.53 | 3.64 | 3.97 |
EV/FCF Ratio | 13.53 | 6.72 | 7.19 | 77.01 | 3.04 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.00 | 0.07 | 0.06 | 0.01 |
Debt / FCF Ratio | 0.01 | 0.01 | 0.01 | 1.70 | 0.06 | - |
Net Debt / Equity Ratio | -0.38 | -0.28 | -0.19 | -0.12 | -0.24 | -0.09 |
Net Debt / EBITDA Ratio | -0.59 | -0.51 | -0.49 | -0.43 | -0.92 | -0.28 |
Net Debt / FCF Ratio | -0.75 | -0.92 | -1.17 | -11.06 | -0.90 | 2.45 |
Asset Turnover | 1.91 | 1.99 | 1.63 | 1.65 | 1.32 | 1.38 |
Inventory Turnover | 4.81 | 3.70 | 3.16 | 3.97 | 3.03 | 2.91 |
Quick Ratio | 1.27 | 0.96 | 0.69 | 0.75 | 1.15 | 0.93 |
Current Ratio | 2.01 | 2.21 | 1.97 | 2.34 | 2.35 | 2.64 |
Return on Equity (ROE) | 49.30% | 43.72% | 29.78% | 19.87% | 19.59% | 20.20% |
Return on Assets (ROA) | 24.71% | 22.79% | 15.45% | 10.77% | 10.08% | 12.07% |
Return on Invested Capital (ROIC) | 72.78% | 57.12% | 33.49% | 22.63% | 21.93% | 25.07% |
Return on Capital Employed (ROCE) | 58.90% | 50.30% | 33.20% | 23.00% | 21.60% | 26.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 6.43% | 17.55% | 20.57% | 18.30% | 22.18% | 17.33% |
FCF Yield | 7.00% | 13.74% | 12.09% | 1.03% | 30.40% | -3.05% |
Dividend Yield | 4.63% | 15.19% | 16.89% | 12.11% | - | 11.24% |
Payout Ratio | 59.93% | 44.40% | 37.83% | 60.86% | 54.95% | 85.72% |
Buyback Yield / Dilution | - | - | - | - | - | 15.35% |
Total Shareholder Return | 4.63% | 15.19% | 16.89% | 12.11% | - | 26.58% |